Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin with Capecitabine and Radiation for Rectal Cancer
NCT00745134Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2008
- Primary completion
- Nov 2022
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in rectal cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2008; status: terminated.
02
Drugs
curcumin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00745134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745134.